US equities |
MU $924.30 ▼-3.03% NVDA $220.52 ▼-3.50% AAPL $342.70 ▲+0.42% AMD $572.51 ▼-5.45% META $736.21 ▼-3.45% TSLA $364.16 ▼-2.95% SPCX $151.77 ▼-3.05% SNDK $1,414.27 ▼-4.59%
FinancialContent

iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

104.75 -2.96 (-2.75%)
Delayed Quote Updated: 2:34 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about iRhythm Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
Following completion of the forensic investigation, company begins notifying impacted individuals 
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
From iRhythm
Via GlobeNewswire
News headline image
iRhythm to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Holdings Announces Second Quarter 2026 Financial Results
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Holdings to Participate in Upcoming Investor Conferences
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Holdings Announces First Quarter 2026 Financial Results
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference
From iRhythm
Via GlobeNewswire
News headline image
New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
From iRhythm
Via GlobeNewswire
News headline image
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Holdings Appoints Jason Patten to its Board of Directors
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
From iRhythm
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
From iRhythm
Via GlobeNewswire
News headline image
From Hype to P&L: Hospitals Now Buying AI That Pays
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. 
From USA News Group
Via GlobeNewswire
News headline image
New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population
From iRhythm
Via GlobeNewswire
News headline image
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies to Participate in Upcoming Investor Conferences
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies Announces Third Quarter 2025 Financial Results
From iRhythm
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025
From iRhythm
Via GlobeNewswire
News headline image
IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service
From iRhythm
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >